Multimodal PET studies indicated that ADNC, and particularly tau accumulation, significantly impact both cognitive dysfunction and glucose metabolism in DLB, which underscores the importance of AD-related co-pathologies in the clinical course and management of DLB patients [140]. Here, MAPT is linked to Alzheimer disease.